These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16171734)

  • 1. Extended use of the oral contraceptive pill--is it an acceptable option for the adolescent?
    Omar H; Kives S; Allen L
    J Pediatr Adolesc Gynecol; 2005 Aug; 18(4):285-8. PubMed ID: 16171734
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol.
    Anderson FD; Gibbons W; Portman D
    Contraception; 2006 Mar; 73(3):229-34. PubMed ID: 16472561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables.
    Rad M; Kluft C; Ménard J; Burggraaf J; de Kam ML; Meijer P; Sivin I; Sitruk-Ware RL
    Am J Obstet Gynecol; 2006 Jul; 195(1):72-7. PubMed ID: 16545330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial.
    Anderson FD; Gibbons W; Portman D
    Am J Obstet Gynecol; 2006 Jul; 195(1):92-6. PubMed ID: 16813747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical study of transdermal contraceptive patch in Thai adolescence women.
    Piyasirisilp R; Taneepanichskul S
    J Med Assoc Thai; 2008 Feb; 91(2):137-41. PubMed ID: 18389975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seasonale.
    Med Lett Drugs Ther; 2004 Feb; 46(1175):9. PubMed ID: 14749609
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral contraceptive pill use and abnormal menstrual cycles in women with severe condylar resorption: a case for low serum 17beta-estradiol as a major factor in progressive condylar resorption.
    Gunson MJ; Arnett GW; Formby B; Falzone C; Mathur R; Alexander C
    Am J Orthod Dentofacial Orthop; 2009 Dec; 136(6):772-9. PubMed ID: 19962599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive.
    Kaunitz AM; Portman DJ; Hait H; Reape KZ
    Contraception; 2009 May; 79(5):350-5. PubMed ID: 19341846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lybrel--a continuous oral contraceptive.
    Med Lett Drugs Ther; 2007 Jul; 49(1266):61-2. PubMed ID: 17652998
    [No Abstract]   [Full Text] [Related]  

  • 10. Menstrual-cycle-related symptoms: a review of the rationale for continuous use of oral contraceptives.
    Archer DF
    Contraception; 2006 Nov; 74(5):359-66. PubMed ID: 17046376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptive tolerance: does the type of pill matter?
    Moreau C; Trussell J; Gilbert F; Bajos N; Bouyer J
    Obstet Gynecol; 2007 Jun; 109(6):1277-85. PubMed ID: 17540798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding patterns of women using extended regimens of the contraceptive vaginal ring.
    Barreiros FA; Guazzelli CA; de Araújo FF; Barbosa R
    Contraception; 2007 Mar; 75(3):204-8. PubMed ID: 17303490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study.
    Strokosch GR; Friedman AJ; Wu SC; Kamin M
    J Adolesc Health; 2006 Dec; 39(6):819-27. PubMed ID: 17116511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol for contraception and control of menstrual symptoms.
    Jensen JT; Archer DF
    Expert Opin Pharmacother; 2008 Feb; 9(2):319-27. PubMed ID: 18201154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trial.
    Maloney JM; Dietze P; Watson D; Niknian M; Lee-Rugh S; Sampson-Landers C; Korner P
    Obstet Gynecol; 2008 Oct; 112(4):773-81. PubMed ID: 18827119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents.
    Molina RC; Sandoval JZ; Montero AV; Oyarzún PG; Molina TG; González EA
    J Pediatr Adolesc Gynecol; 2009 Feb; 22(1):25-31. PubMed ID: 19232299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive.
    Devineni D; Skee D; Vaccaro N; Massarella J; Janssens L; LaGuardia KD; Leung AT
    J Clin Pharmacol; 2007 Apr; 47(4):497-509. PubMed ID: 17389559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen.
    Sulak PJ; Kuehl TJ; Coffee A; Willis S
    Am J Obstet Gynecol; 2006 Oct; 195(4):935-41. PubMed ID: 16647684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Brenner P
    Contraception; 2006 Oct; 74(4):354; author reply 354-5. PubMed ID: 16982246
    [No Abstract]   [Full Text] [Related]  

  • 20. Continuous oral contraception. Strategies for managing breakthrough bleeding.
    Freeman SB
    Adv Nurse Pract; 2008 Aug; 16(8):36-8. PubMed ID: 19181174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.